ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

NIH Investigating Cohn Records Leak

August 15, 1986

Asks BSC For Advice On Centers Funding, Other Pressing Issues, But Doesn’t Get Any

March 30, 1990

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986